PREIMPLANTATION GENETIC SCREENING (PGS) TECHNOLOGY MARKET ANALYSIS BY TYPE, APPLICATION, REGIONS AND COMPANIES FORECAST

  2024-11-27 |   Pages: 200+ |   Report ID: BYR-29813 |   Pharmaceutics

Historical data: 2017 - 2023

Forecast period: 2025 - 2031

Quantitative units: Revenue in USD million and CAGR from 2025 to 2031

Report coverage: Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Preimplantation Genetic Screening (PGS) Technology Market

Image

1.1 SCOPE OF THE REPORT

1.2 MARKET SEGMENT ANALYSIS

1.3 REGULATORY SCENARIO BY REGION/COUNTRY

1.4 MARKET INVESTMENT SCENARIO STRATEGIC

1.5 MARKET ANALYSIS BY TYPE (USD MILLION)

1.6 MARKET ANALYSIS BY APPLICATION (USD MILLION)

2.1 DRIVER, RESTRAINT, CHALLENGE AND OPPORTUNITIES ANALYSIS

  2.1.1 MARKET DRIVER ANALYSIS

  2.1.2 MARKET RESTRAINT ANALYSIS

  2.1.3 MARKET OPPORTUNITY

  2.1.4 MARKET CHALLENGES

3.1 INDUSTRY TRENDS

  3.1.1 SWOT ANALYSIS

  3.1.2 PESTEL ANALYSIS

  3.1.3 PORTER’S FIVE FORCES ANALYSIS

3.2 POTENTIAL MARKET AND GROWTH POTENTIAL ANALYSIS

4.1 COVID-19 ANALYSIS

5.1 GLOBAL PREIMPLANTATION GENETIC SCREENING (PGS) TECHNOLOGY MARKET, SALES AREA, TYPE

5.2 MERGERS & ACQUISITIONS, PARTNERSHIPS, PRODUCT LAUNCH, AND COLLABORATION IN GLOBAL PREIMPLANTATION GENETIC SCREENING (PGS) TECHNOLOGY MARKET

7.1 GLOBAL PREIMPLANTATION GENETIC SCREENING (PGS) TECHNOLOGY MARKET SIZE AND SHARE (2017 - 2031) (USD MILLION)

8.1 GLOBAL PREIMPLANTATION GENETIC SCREENING (PGS) TECHNOLOGY MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)

8.2 GLOBAL PREIMPLANTATION GENETIC SCREENING (PGS) TECHNOLOGY MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)

9.1 GLOBAL PREIMPLANTATION GENETIC SCREENING (PGS) TECHNOLOGY MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)

9.2 GLOBAL PREIMPLANTATION GENETIC SCREENING (PGS) TECHNOLOGY MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)

10.1 GLOBAL PREIMPLANTATION GENETIC SCREENING (PGS) TECHNOLOGY MARKET SIZE AND SHARE BY REGION (2017 - 2023) (USD MILLION)

10.2 GLOBAL PREIMPLANTATION GENETIC SCREENING (PGS) TECHNOLOGY MARKET SIZE AND SHARE BY REGION (2025 - 2031) (USD MILLION)

11.1 NORTH AMERICA PREIMPLANTATION GENETIC SCREENING (PGS) TECHNOLOGY MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)

11.2 NORTH AMERICA PREIMPLANTATION GENETIC SCREENING (PGS) TECHNOLOGY MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)

11.3 NORTH AMERICA PREIMPLANTATION GENETIC SCREENING (PGS) TECHNOLOGY MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)

11.4 NORTH AMERICA PREIMPLANTATION GENETIC SCREENING (PGS) TECHNOLOGY MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)

11.5 NORTH AMERICA PREIMPLANTATION GENETIC SCREENING (PGS) TECHNOLOGY MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)

11.6 NORTH AMERICA PREIMPLANTATION GENETIC SCREENING (PGS) TECHNOLOGY MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)

12.1 EUROPE PREIMPLANTATION GENETIC SCREENING (PGS) TECHNOLOGY MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)

12.2 EUROPE PREIMPLANTATION GENETIC SCREENING (PGS) TECHNOLOGY MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)

12.3 EUROPE PREIMPLANTATION GENETIC SCREENING (PGS) TECHNOLOGY MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)

12.4 EUROPE PREIMPLANTATION GENETIC SCREENING (PGS) TECHNOLOGY MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)

12.5 EUROPE PREIMPLANTATION GENETIC SCREENING (PGS) TECHNOLOGY MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)

12.6 EUROPE PREIMPLANTATION GENETIC SCREENING (PGS) TECHNOLOGY MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)

13.1 ASIA PACIFIC PREIMPLANTATION GENETIC SCREENING (PGS) TECHNOLOGY MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)

13.2 ASIA PACIFIC PREIMPLANTATION GENETIC SCREENING (PGS) TECHNOLOGY MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)

13.3 ASIA PACIFIC PREIMPLANTATION GENETIC SCREENING (PGS) TECHNOLOGY MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)

13.4 ASIA PACIFIC PREIMPLANTATION GENETIC SCREENING (PGS) TECHNOLOGY MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)

13.5 ASIA PACIFIC PREIMPLANTATION GENETIC SCREENING (PGS) TECHNOLOGY MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)

13.6 ASIA PACIFIC PREIMPLANTATION GENETIC SCREENING (PGS) TECHNOLOGY MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)

14.1 LATIN AMERICA PREIMPLANTATION GENETIC SCREENING (PGS) TECHNOLOGY MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)/p>

14.2 LATIN AMERICA PREIMPLANTATION GENETIC SCREENING (PGS) TECHNOLOGY MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)

14.3 LATIN AMERICA PREIMPLANTATION GENETIC SCREENING (PGS) TECHNOLOGY MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)

14.4 LATIN AMERICA PREIMPLANTATION GENETIC SCREENING (PGS) TECHNOLOGY MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)

14.5 LATIN AMERICA PREIMPLANTATION GENETIC SCREENING (PGS) TECHNOLOGY MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)

14.6 LATIN AMERICA PREIMPLANTATION GENETIC SCREENING (PGS) TECHNOLOGY MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)

15.1 MIDDLE EAST & AFRICA PREIMPLANTATION GENETIC SCREENING (PGS) TECHNOLOGY MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)

15.2 MIDDLE EAST & AFRICA PREIMPLANTATION GENETIC SCREENING (PGS) TECHNOLOGY MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)

15.3 MIDDLE EAST & AFRICA PREIMPLANTATION GENETIC SCREENING (PGS) TECHNOLOGY MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)

15.4 MIDDLE EAST & AFRICA PREIMPLANTATION GENETIC SCREENING (PGS) TECHNOLOGY MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)

15.5 MIDDLE EAST & AFRICA PREIMPLANTATION GENETIC SCREENING (PGS) TECHNOLOGY MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)

15.6 MIDDLE EAST & AFRICA PREIMPLANTATION GENETIC SCREENING (PGS) TECHNOLOGY MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031)< (USD MILLION)/p>

16.1 Illumina

  16.1.1 COMPANY DETAILS

  16.1.2 FINANCIALS (USD MILLION)

  16.1.3 PRODUCT SUMMARY

  16.1.4 RECENT DEVELOPMENTS

16.2 Oxford Gene Technology

16.3 PerkinElmer

16.4 Thermo Fisher Scientific

16.5 Takara Bio

16.6 Agilent Technologies

16.7 Genea

16.8 Natera

16.9 Coopersurgical

16.10 INVICTA

16.11 Progenesis

16.12 Igenomix

16.13 Reproductive Health and Wellness Center

18.1 METHODOLOGY

18.2 RESEARCH DATA SOURCE

  18.2.1 SECONDARY DATA

  18.2.2 KEY DATA FROM SECONDARY

  18.2.3 PRIMARY DATA

  18.2.4 KEY DATA FROM PRIMARY

  18.2.5 INDUSTRY INSIGHT FROM PROFESSIONAL LEADERS

  18.2.6 MARKET ESTIMATION

  18.2.7 MARKET ESTIMATION: TOP-DOWN AND BOTTOM-UP APPROACH

  18.2.8 LEGAL DISCLAIMER

Market Segments

Market by Type :

Next-generation Sequencing
Polymerase Chain Reaction
Fluorescence in Situ Hybridization
Comparative Genomic Hybridization
Single-nucleotide Polymorphism

Market by Application :

Maternity Centers & Fertility Clinics
Hospitals
Research Laboratories & Academic Institutes
Others

Companies

Illumina
Oxford Gene Technology
PerkinElmer
Thermo Fisher Scientific
Takara Bio
Agilent Technologies
Genea
Natera
Coopersurgical
INVICTA
Progenesis
Igenomix
Reproductive Health and Wellness Center

BROWSE INDUSTRY

  1. Consumer Goods
  2. Healthcare
  3. Food & Beverage
  4. Heavy Industry
  5. Service Industries
  6. FMCG
  7. Life Sciences
  8. Technology & Media
  9. Machinery & Equipment

    WHY CHOOSE US

  •   PROACTIVE
  • We manage our resources 24/7 to identify issues and address them before they become problems.

  •   QUALITY & RELIABILITY
  • We are committed to providing reliable and highly accurate data with an excellent quality control system.

  •   GLOBAL OUTREACH
  • 6 Major regions and 40+ countries level analysis accomplished.

  •   COMPETITIVE PRICING
  • Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery.